Latest News About Lantern updates AI platform through RADR expansion

Updated 2026-06-18 00:09

Lantern is billed as an AI-driven revenue tool to accelerate revenue workflows, with claims of 28% faster deal velocity through timed upsell outreach. A Champion Agent monitors personnel shifts across the customer base and improve response rates for certain teams. In pharma, Lantern Pharma reports 2026 progress, cutting R&D spend by 47% while progressing clinical programs, launching a multi-agent AI platform with Zeta.ai and expanding an AI Center of Excellence in India. These developments illustrate Lantern's growth into AI-powered drug discovery partnerships, supported by ongoing financing to fuel expansion.

Sources

news

news

www.newswire.ca